Pablo Velasco

Read here a new review series of Haematologica on pediatric acute leukemias and myelodysplastic syndromes focusing on the challenges in a field in which much progress has been made during the last decades. doi.org/10.3324/haemat…

How many platelets do I need to perform a safe lumbar puncture in patients with hematologic malignancies? 40 is the new 50! haematologica.org/article/view/1…

Ahora mismo,29 chicos con una enfermedad rara,#drepanocitosis, y glóbulos rojos con forma de 🌜,viajan desde Almería,Barcelona,Bilbao,Lleida, Madrid,Mallorca,Valencia y Sevilla,aunque proceden de muchas otras ciudades,para encontrarse en las #ColoniasASAFE2025. ¡Empieza la magia!

Read the new study demonstrating the benefits of the combination of allopurinol with 6‑mercaptopurine in children with acute lymphoblastic leukemia. An important step forward in childhood leukemia care. haematologica.org/article/view/1…

Thrilled to see our latest study published! 🚀 
We present a novel dual immunotherapy approach for T-ALL. 
 Huge thanks to the amazing team @Menendez_Lab and all collaborators who made this possible, @ToribioLab @onechaintx and others! 
🔗 link.springer.com/article/10.118…

It has been a great experience of coordination and collaboration with outstanding professionals and societies The pandemic was a challenge for all of us, and I believe projects like this show that by sharing data and efforts, we can overcome anything I hope that the ethical, legal, and logistical structure we built will help us respond better and faster to future health crises I would also like to thank all those who were on the front lines and to especially honor the memory of the patients, families, and colleagues we lost during the pandemic linkedin.com/posts/childhoo…

TP53-mutated acute myeloid leukemia and myelodysplastic syndrome are now well established as their own unique diagnostic entity, characterized by an exceptionally poor prognosis and inadequate therapeutic options. ow.ly/XMBu50WagUw #BloodSpotlight #myeloidneoplasia

Mujeres 🩸unidas resolviendo dudas sobre #drepanocitosis #anemiafalciforme @AsafeFalciforme

📄Amb motiu del Dia Internacional de la Malaltia de Cèl·lules Falciformes, que es celebra avui 19 de juny, el Grup de Treball d'Hematologia de la SCP ha publicat una nota sobre aquesta malaltia ➡️cutt.ly/crQNQOhy

¡Hoy celebramos el #DíaMundialEnfermedadCélulasFalciformes! #WorldSickleCellDay Nuestra tesorera, Nuria Machío, luchadora innata contra la enfermedad, nos dedica unas palabras. @FEDER_ONG @NoInvisibles @sehh_es @SETS_es 👉🏾asafefalciforme.org

La #drepanocitosis o ECF es la enfermedad minoritaria más frecuente en España, única enfermedad hematológica incluida en el cribado neonatal.Aún así, es poco conocida y quienes la sufrimos a menudo somos víctimas del estigma. ¡En el #WorldSickleCellDay reclamamos + visibilidad!

A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia - Clinical Lymphoma, Myeloma and Leukemia clinical-lymphoma-myeloma-leukemia.com/article/S2152-…

Blinatumomab Use in Pediatric B-ALL: Where are we now? ashpublications.org/bloodadvances/…

Rapid in vivo Drug Response Prediction Using Leukemia Cell Grafts in Zebrafish Embryos pubmed.ncbi.nlm.nih.gov/40489456/

Felicitats CristinaCarreras i MartaGarcía pel premi rebut al projecte del protocol de maneig d'anèmia ferropènica a pediatria. És un projecte desenvolupat des del grup de treball d'hematologia pediàtrica de la SCP , que esperem que estigui aviat publicat perquè els pediatres de Catalunya en pugui gaudir. Fem hematologia a la SCP, #redSCP

El Pol no va poder sobreviure a una leucèmia poc comuna perquè no hi havia tractaments efectius. Ajuda'ns en la recerca amb la campanya #elLegadodePol! Info al post! 👇

Although there is a body of evidence linking cancer stem cells to therapy resistance in acute myeloid leukemia, some work has challenged this idea. ow.ly/oYcr50W5eAP #hematopoiesisandstemcells

Piden que se amplíe el uso de la oncología de precisión a los menores sciencemediacentre.es/piden-que-se-a…